These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35267013)

  • 41. Letter to the Editor Re: Serum Calprotectin in Adolescents With Inflammatory Bowel Disease.
    Day AS; Ho SSC; Leach ST
    J Pediatr Gastroenterol Nutr; 2019 Jun; 68(6):e109. PubMed ID: 30908387
    [No Abstract]   [Full Text] [Related]  

  • 42. [Aseptic disseminated abscesses: association with neutrophilic skin diseases and chronic inflammatory bowel diseases].
    André M; Frances C; Aumaitre O; Piette JC
    Ann Dermatol Venereol; 1997; 124(5):404-5. PubMed ID: 9739900
    [No Abstract]   [Full Text] [Related]  

  • 43. Reply to letter to the editor "tDCS effect on cognitive performance in Parkinson's disease" by Biundo et al.
    Cotelli M; Manenti R; Brambilla M; Borroni B
    Mov Disord; 2016 Aug; 31(8):1253-5. PubMed ID: 27270985
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter to the Editor. Magnetic resonance-guided focused ultrasound thalamotomy for Parkinson's disease.
    Chapman M; Tarshis J
    J Neurosurg; 2018 Jan; 128(1):322-323. PubMed ID: 28862542
    [No Abstract]   [Full Text] [Related]  

  • 45. Letter to the Editor: Patients With Inflammatory Bowel Disease Demonstrate an Inherent Lack of Psychopathology.
    Taft TH; Quinton S; Tomasino K; Craven M; Guadagnoli L; Bedell A; Hanauer S
    Inflamm Bowel Dis; 2019 Aug; 25(9):e114. PubMed ID: 30989208
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter to the Editor: "Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson's disease: a randomised controlled trial".
    Özden F
    Physiotherapy; 2021 Mar; 110():87. PubMed ID: 32736882
    [No Abstract]   [Full Text] [Related]  

  • 47. Letter to the Editor: Substantia nigra hyperechogenicity and Parkinson's disease surgery.
    Bor-Seng-Shu E; de Andrade DC; de Lima Oliveira M; Fonoff ET; Barbosa ER; Teixeira MJ
    J Neurosurg; 2014 Jun; 120(6):1500-2. PubMed ID: 24702328
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter to the editor, "Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease".
    Koga S; Dickson DW; Wszolek ZK
    Parkinsonism Relat Disord; 2020 Oct; 79():130. PubMed ID: 32921567
    [No Abstract]   [Full Text] [Related]  

  • 49. In reply to the letter to the editor regarding "Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study".
    Zenesini C; Baldin E; Vignatelli L; D'Alessandro R
    J Neurol Sci; 2020 Jan; 408():116511. PubMed ID: 31732173
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter to the Editor: "Subthalamic Nucleus Stimulation Impairs Motivation: Implication for Apathy in Parkinson's Disease".
    Martínez-Fernández R
    Mov Disord; 2020 Jun; 35(6):1084. PubMed ID: 32562457
    [No Abstract]   [Full Text] [Related]  

  • 51. Can stress trigger Parkinson's disease?
    Djamshidian A; Lees AJ
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):878-81. PubMed ID: 24259593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reply to Letter to the Editor: 'Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson's disease: a randomised controlled trial'.
    Pazzaglia C; Imbimbo I; Tranchita E; Minganti C; Ricciardi D; Monaco RL; Parisi A; Padua L
    Physiotherapy; 2021 Mar; 110():88-89. PubMed ID: 32798048
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter to the Editor about the Ongre et al. publication: 'Progression of fatigue in Parkinson's disease-a 9-year follow-up' (Eur J Neurol 2020. doi: 10.1111/ene.14520).
    Vollstedt EJ; Warrlich E; Hauptmann B; Hanssen H; Klein C; Kasten M;
    Eur J Neurol; 2021 Jun; 28(6):e35-e36. PubMed ID: 33459455
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter to the Editor Regarding "Voice Tremor in Parkinson's Disease: An Acoustic Study" by Gillivan-Murphy et al, In Press in Journal of Voice.
    Gath I
    J Voice; 2019 Sep; 33(5):813.e7. PubMed ID: 30100163
    [No Abstract]   [Full Text] [Related]  

  • 55. Parkinson disease pathology in inflammatory bowel disease.
    Wood H
    Nat Rev Neurol; 2024 Apr; 20(4):203. PubMed ID: 38443475
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis?
    Quattrone D; Richards A; Reininghaus U; Vassos E; O'Donovan M; Lewis C; Di Forti M
    Psychol Med; 2020 Jan; 50(1):173-176. PubMed ID: 31533866
    [No Abstract]   [Full Text] [Related]  

  • 57. Response to letter to Editor.
    Iwaki H; Ascherio A
    J Neurol Sci; 2019 Feb; 397():48-49. PubMed ID: 30586656
    [No Abstract]   [Full Text] [Related]  

  • 58. [Chronic anemia in inflammatory bowel diseases: review].
    Vijverman A; Belaiche J; Louis E
    Rev Med Liege; 2005 Nov; 60(11):888-92. PubMed ID: 16402536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson's disease: review and meta-analysis. Response to letter to the editor by Zheng et al.
    Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JAG
    Eur J Neurol; 2021 Feb; 28(2):e13-e14. PubMed ID: 33037706
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter to the Editor regarding Wang Y, Liu Y, Yan H. 2020. Effect of long-term particulate matter exposure on Parkinson's risk.
    Kawada T
    Environ Geochem Health; 2021 May; 43(5):1759-1760. PubMed ID: 33411167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.